First Time Loading...

Somnomed Ltd
ASX:SOM

Watchlist Manager
Somnomed Ltd Logo
Somnomed Ltd
ASX:SOM
Watchlist
Price: 0.21 AUD Market Closed
Updated: Apr 29, 2024

Somnomed Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Somnomed Ltd
Cash from Financing Activities Peer Comparison

Comparables:
NTI
IPD
C
CYC
COH
EMV

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Somnomed Ltd
ASX:SOM
Cash from Financing Activities
AU$6.3m
CAGR 3-Years
-19%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Neurotech International Ltd
ASX:NTI
Cash from Financing Activities
AU$9.4m
CAGR 3-Years
250%
CAGR 5-Years
23%
CAGR 10-Years
N/A
ImpediMed Ltd
ASX:IPD
Cash from Financing Activities
AU$28m
CAGR 3-Years
3%
CAGR 5-Years
192%
CAGR 10-Years
N/A
C
Cyclopharm Ltd
ASX:CYC
Cash from Financing Activities
-AU$1m
CAGR 3-Years
-1%
CAGR 5-Years
-24%
CAGR 10-Years
2%
Cochlear Ltd
ASX:COH
Cash from Financing Activities
-AU$377.1m
CAGR 3-Years
N/A
CAGR 5-Years
-9%
CAGR 10-Years
-21%
EMvision Medical Devices Ltd
ASX:EMV
Cash from Financing Activities
AU$2.5m
CAGR 3-Years
-16%
CAGR 5-Years
8%
CAGR 10-Years
N/A

See Also

What is Somnomed Ltd's Cash from Financing Activities?
Cash from Financing Activities
6.3m AUD

Based on the financial report for Dec 31, 2023, Somnomed Ltd's Cash from Financing Activities amounts to 6.3m AUD.

What is Somnomed Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-8%

Over the last year, the Cash from Financing Activities growth was -46%. The average annual Cash from Financing Activities growth rates for Somnomed Ltd have been -19% over the past three years , -8% over the past five years .